Back to UBS Group AG UBS Group AG

ATYRATYR
25 quarters

Position history for UBS Group AGUBS Group AG's holdings in ATYR PHARMA INC

UBS Group AG holds 1.5M shares of ATYR (ATYR PHARMA INC), worth $914,097 as of 2026-Q2. The position was decreased (-60.4% shares). ATYR represents 0.0% of UBS Group AG's portfolio.

Current Value

$914,097

Current Shares

1.5M

Total Value Change

+$900,097

Total Shares Change

+1.5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
1.5M
-60.4%
$914,0970.0%$0.60
0
2026-Q1
Increased
3.9M
+137.9%
$3M0.0%$0.96
43
2025-Q4
Decreased
1.6M
-63.9%
$1.3M0.0%$0.75
0
2025-Q3
Increased
4.5M
+158.1%
$3.2M0.0%$0.80
43
2025-Q2
Increased
1.7M
+6.6%
$8.9M0.0%$5.03
29
2025-Q1
Increased
1.6M
+613.1%
$4.9M0.0%$3.13
43
2024-Q4
New
229,576
-
$831,0650.0%$3.51
34
2024-Q2
Exited
0
-100.0%
$00.0%$1.56
0
2024-Q1
Increased
20,192
+22.9%
$39,3740.0%$1.95
17
2023-Q4
Increased
16,426
+273.4%
$23,1610.0%$1.41
21
2023-Q3
New
4,399
-
$6,9500.0%$1.58
25
2023-Q2
Exited
0
-100.0%
$00.0%$2.12
0
2023-Q1
New
1,000
-
$2,1000.0%$2.10
18
2022-Q4
Exited
0
-100.0%
$00.0%$2.19
0
2022-Q3
Increased
5,975
+198.8%
$18,0000.0%$2.85
20
2022-Q2
Decreased
2,000
-50.0%
$6,0000.0%$2.75
0
2022-Q1
Increased
4,000
+253.4%
$21,0000.0%$5.45
21
2021-Q4
New
1,132
-
$8,0000.0%$7.50
25
2021-Q3
Exited
0
-100.0%
$00.0%$8.87
0
2021-Q2
New
3,164
-
$15,0000.0%$4.78
28
2020-Q4
Exited
0
-100.0%
$00.0%$3.94
0
2020-Q3
Decreased
1,637
-95.9%
$5,0000.0%$3.27
0
2020-Q2
Increased
40,049
+5.4%
$178,0000.0%$4.58
24
2020-Q1
Increased
37,999
+1002.1%
$106,0000.0%$2.87
24
2019-Q4
New
3,448
-
$14,0000.0%$4.17
27

Other major holders of ATYR: FEDERATED HERMES, INC., FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used